“The challenges inherent in the pediatric device clinical trial process can significantly impede the path to commercialization of much-needed medical devices for children,” says Kolaleh Eskandanian, Ph.D., MBA, PMP, vice president and chief innovation officer at Children’s National Health System. “At the symposium, our experts will provide the latest insights for biohealth innovators and clinicians on progressive methods of validating medical devices for children.

The symposium, which co-locates with AdvaMed’s The MedTech Conference, presents multidisciplinary panel discussions that address critical issues related to pediatric device development, regulatory processes, device clinical trials and gaps in pediatric healthcare innovation. Key insights from the symposium will inform a white paper detailing best practices for stakeholders involved in stimulating pediatric device innovation and to bring solutions to market faster to benefit children.